Creating and testing innovative methods to improve and accelerate the drug development process and find new treatments for patients faster. Learn more.
A scientific society honored NCATS scientists for creating a screening test to identify molecules that block the growth of new blood vessels. The test could be useful in cancer research.
People with chronically itchy skin, take heart. NCATS researchers report that blocking a receptor on the surface of spinal cord neurons may help relieve the constant need to scratch. The study appeared online in Science Translational Medicine.
A team of NCATS researchers developed an approach to rapidly test thousands of existing drugs to identify promising therapies for myositis, a rare muscle disease.
Developing new approaches and technologies to identify and validate potential drug targets in a more efficient and predictable way.
Enhancing testing systems to assess the effects of chemical compounds on cellular, molecular or biochemical processes of interest.
Creating probes to investigate biological processes and optimizing them to become potential drug candidates.
Using state-of-the-art resources to enable the ongoing operation of all NCATS translational research activities.
Target Identification & Validation
Assay Development & Screening
Probe Development & Lead Optimization
Work with Us
NCATS pre-clinical programs and resources focus on key obstacles and inefficiencies in the translational process, overcoming bottlenecks that slow the development of new treatments for patients.
Learn more about how to access NCATS programs and expertise.
Learn more about NCATS’ Achievements in Advancing Translational Sciences.
Translational Science Spectrum
Learn more about the science of translation.